Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 73

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 73
---
 purchase, pledge, hypothecate or otherwise dispose
of, directly or indirectly, any of our shares of common stock or any securities convertible into, or exercisable or exchangeable for,
shares of common stock, subject to customary exceptions. The placement agent may waive the terms of these lock-up agreements in its sole
discretion and without notice. In addition, we have agreed to not issue any securities that are subject to a price reset based on the
trading prices of our common stock or upon a specified or contingent event in the future or enter into any agreement to issue securities
at a future determined price for a period of one year following the closing date of this offering. The placement agent may waive this
prohibition in its sole discretion and without notice.

Regulation M

The placement agent may be deemed
to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit
realized on the resale of the securities sold by it while acting as principal might be deemed to be underwriting discounts or commissions
under the Securities Act. As an underwriter, the placement agent would be required to comply with the requirements of the Securities Act
and the Securities Exchange Act of 1934, as amended, or the Exchange Act, including, without limitation, Rule 10b-5 and Regulation M under
the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our securities by the placement agent acting
as principal. Under these rules and regulations, the placement agent (i) may not engage in any stabilization activity in connection
with our securities and (ii) may not bid for or purchase any of our securities or attempt to induce any person to purchase any of
our securities, other than as permitted under the Exchange Act, until it has completed its participation in the distribution.

| 43 |

Indemnification

We have agreed to indemnify the
placement agent against certain liabilities, including certain liabilities arising under the Securities Act, or to contribute to payments
that the placement agent may be required to make for these liabilities.

Determination of Offering Price and Warrant Exercise Price

The actual offering price of the
securities we are offering has been negotiated between us and the investors in the offering based on the trading of our shares
of common stock prior to the offering, among other things. Other factors considered in determining the public offering price of the securities
we are offering include our history and prospects, the stage of